HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

J. Biol. Chem., Vol. 276, Issue 17, 14359-14365, April 27, 2001

This Article Full Text Full Text (PDF) All Versions of this Article: 276/17/14359    most recent M010100200v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kayyali, U. S. Articles by Hassoun, P. M. Search for Related Content PubMed PubMed Citation Articles by Kayyali, U. S. Articles by Hassoun, P. M.

Phosphorylation of Xanthine Dehydrogenase/Oxidase in Hypoxia^*

Usamah S. Kayyali, Cameron Donaldson, Hailu Huang, Raja Abdelnour, and Paul M. Hassoun

From the Department of Medicine, Pulmonary and Critical Care Division, Tupper Research Institute, New England Medical Center and Tufts University School of Medicine, Boston, Massachusetts 02111

The enzyme xanthine oxidase (XO) has been implicated in the pathogenesis of several disease processes, such as ischemia-reperfusion injury, because of its ability to generate reactive oxygen species. The expression of XO and its precursor xanthine dehydrogenase (XDH) is regulated at pre- and posttranslational levels by agents such as lipopolysaccharide and hypoxia. Posttranslational modification of the protein, for example through thiol oxidation or proteolysis, has been shown to be important in converting XDH to XO. The possibility of posttranslational modification of XDH/XO through phosphorylation has not been adequately investigated in mammalian cells, and studies have reported conflicting results. The present report demonstrates that XDH/XO is phosphorylated in rat pulmonary microvascular endothelial cells (RPMEC) and that phosphorylation is greatly increased (~50-fold) in response to acute hypoxia (4 h). XDH/XO phosphorylation appears to be mediated, at least in part, by casein kinase II and p38 kinase as inhibitors of these kinases partially prevent XDH/XO phosphorylation. In addition, the results indicate that p38 kinase, a stress-activated kinase, becomes activated in response to hypoxia (an ~4-fold increase after 1 h of exposure of RPMEC to hypoxia) further supporting a role for this kinase in hypoxia-stimulated XDH/XO phosphorylation. Finally, hypoxia-induced XDH/XO phosphorylation is accompanied by a 2-fold increase in XDH/XO activity, which is prevented by inhibitors of phosphorylation. In summary, this study shows that XDH/XO is phosphorylated in hypoxic RPMEC through a mechanism involving p38 kinase and casein kinase II and that phosphorylation is necessary for hypoxia-induced enzymatic activation.

This article has been cited by other articles:

				A. Boueiz, M. Damarla, and P. M. Hassoun Xanthine oxidoreductase in respiratory and cardiovascular disorders Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L830 - L840. [Abstract] [Full Text] [PDF]

				R.-E. E. Abdulnour, X. Peng, J. H. Finigan, E. J. Han, E. J. Hasan, K. G. Birukov, S. P. Reddy, J. E. Watkins III, U. S. Kayyali, J. G. N. Garcia, et al. Mechanical stress activates xanthine oxidoreductase through MAP kinase-dependent pathways Am J Physiol Lung Cell Mol Physiol, September 1, 2006; 291(3): L345 - L353. [Abstract] [Full Text] [PDF]

				R. M. Saraiva, K. M. Minhas, S. V.Y. Raju, L. A. Barouch, E. Pitz, K. H. Schuleri, K. Vandegaer, D. Li, and J. M. Hare Deficiency of Neuronal Nitric Oxide Synthase Increases Mortality and Cardiac Remodeling After Myocardial Infarction: Role of Nitroso-Redox Equilibrium Circulation, November 29, 2005; 112(22): 3415 - 3422. [Abstract] [Full Text] [PDF]

				S. S. An, C. M. Pennella, A. Gonnabathula, J. Chen, N. Wang, M. Gaestel, P. M. Hassoun, J. J. Fredberg, and U. S. Kayyali Hypoxia alters biophysical properties of endothelial cells via p38 MAPK- and Rho kinase-dependent pathways Am J Physiol Cell Physiol, September 1, 2005; 289(3): C521 - C530. [Abstract] [Full Text] [PDF]

				S. Kinugawa, H. Huang, Z. Wang, P. M. Kaminski, M. S. Wolin, and T. H. Hintze A Defect of Neuronal Nitric Oxide Synthase Increases Xanthine Oxidase-Derived Superoxide Anion and Attenuates the Control of Myocardial Oxygen Consumption by Nitric Oxide Derived From Endothelial Nitric Oxide Synthase Circ. Res., February 18, 2005; 96(3): 355 - 362. [Abstract] [Full Text] [PDF]

				C. S. H. Ng, S. Wan, and A. P. C. Yim Pulmonary ischaemia-reperfusion injury: role of apoptosis Eur. Respir. J., February 1, 2005; 25(2): 356 - 363. [Abstract] [Full Text] [PDF]

				A. Webb, R. Bond, P. McLean, R. Uppal, N. Benjamin, and A. Ahluwalia Reduction of nitrite to nitric oxide during ischemia protects against myocardial ischemia-reperfusion damage PNAS, September 14, 2004; 101(37): 13683 - 13688. [Abstract] [Full Text] [PDF]

				K. R. Laderoute, J. M. Calaoagan, M. Knapp, and R. S. Johnson Glucose Utilization Is Essential for Hypoxia-Inducible Factor 1{alpha}-Dependent Phosphorylation of c-Jun Mol. Cell. Biol., May 15, 2004; 24(10): 4128 - 4137. [Abstract] [Full Text] [PDF]

				C. E. Berry and J. M. Hare Xanthine oxidoreductase and cardiovascular disease: molecular mechanisms and pathophysiological implications J. Physiol., March 15, 2004; 555(3): 589 - 606. [Abstract] [Full Text] [PDF]

				G. K. Kumar and J. B. Klein Analysis of expression and posttranslational modification of proteins during hypoxia J Appl Physiol, March 1, 2004; 96(3): 1178 - 1186. [Abstract] [Full Text] [PDF]

				J. S. McNally, M. E. Davis, D. P. Giddens, A. Saha, J. Hwang, S. Dikalov, H. Jo, and D. G. Harrison Role of xanthine oxidoreductase and NAD(P)H oxidase in endothelial superoxide production in response to oscillatory shear stress Am J Physiol Heart Circ Physiol, December 1, 2003; 285(6): H2290 - H2297. [Abstract] [Full Text] [PDF]

				N. Linder, E. Martelin, R. Lapatto, and K. O. Raivio Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions Am J Physiol Cell Physiol, July 1, 2003; 285(1): C48 - C55. [Abstract] [Full Text] [PDF]

				U. S. Kayyali, C. M. Pennella, C. Trujillo, O. Villa, M. Gaestel, and P. M. Hassoun Cytoskeletal Changes in Hypoxic Pulmonary Endothelial Cells Are Dependent on MAPK-activated Protein Kinase MK2 J. Biol. Chem., November 1, 2002; 277(45): 42596 - 42602. [Abstract] [Full Text] [PDF]

				G. Krikun, H. Critchley, F. Schatz, L. Wan, R. Caze, R. N. Baergen, and C. J. Lockwood Abnormal Uterine Bleeding during Progestin-Only Contraception May Result from Free Radical-Induced Alterations in Angiopoietin Expression Am. J. Pathol., September 1, 2002; 161(3): 979 - 986. [Abstract] [Full Text] [PDF]

				A. Barchowsky, N. V. Soucy, K. A. O'Hara, J. Hwa, T. L. Noreault, and A. S. Andrew A Novel Pathway for Nickel-induced Interleukin-8 Expression J. Biol. Chem., June 28, 2002; 277(27): 24225 - 24231. [Abstract] [Full Text] [PDF]

				C. Li and R. M. Jackson Reactive species mechanisms of cellular hypoxia-reoxygenation injury Am J Physiol Cell Physiol, February 1, 2002; 282(2): C227 - C241. [Abstract] [Full Text] [PDF]